| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Outsourcing > The Knowledge Broker & How to Speed up ERP Selections |
|
Advice You - The Knowledge Broker & How to Speed up ERP Selections
Think about the following project to initiate. A company is to select a new software system; for exam According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ple an Enterprise Resource Planning, or ERP system. Finding ERP suppliers is not that hard. Internet ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in is a willing environment to organize this preliminary step in the selection process. Then (or before) lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. you need some requirements and selection criteria. In the next step you should filter the initial gr here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe up to a shortlist of high potentials. Both in the initial long-list phase as in the next sequence wi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro th the short-list, you need to match your demand characteristics with those of the suppliers. The cha ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc lenge pops up in asking the (right) questions – this is usually done in a Request for Information (RF easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi I) or in a later stage the Request For Proposal (RFP). This is the challenge to set the questions up nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n a form that all participants understand the same format. This is a knowledge management problem. Y and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ou request information, but behind this information is a huge amount of knowledge hidden. Even if you ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ask the suppliers to draw some pictures you are not able to compare these. All picture, models and sc ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a hemes are most of the time proprietary. The solution… The solution is to direct to an independent t dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ird party. This could be an independent advisor, not offering (software) solutions. The external adv cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin isor is to prepare a format in which not only the most essential information is gathered (from the su tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen pliers), but also the essential (explicit) knowledge behind it.
The demanding company could still se t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel tup its own requirements. The management advisor -- in the role of knowledge broker -- is to translat ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust these requirements to a universal (not proprietary) form and have the suppliers respond to it. The y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Benefits…
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de level of detail
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ide accurate information.
© 2006 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:IT Consulting in Micro Small Businesses Mobile Car Washing and Doing Business With Hertz Rent-A-Car
|